Adma Biologics (ADMA) Capital Leases (2011 - 2021)
Adma Biologics (ADMA) reported Capital Leases of $6.4 million for Q1 2021, up 250.48% on a YoY basis from $1.8 million in Q1 2020, and up 48.12% quarter-over-quarter from $4.3 million in Q4 2020.
Adma Biologics (ADMA) Capital Leases (2011 - 2021) Analysis & Trends
Adma Biologics has reported Capital Leases for 10 years, with the latest figure at $6.4 million in Q1 2021.
- For the quarter ending Q1 2021, Capital Leases rose 250.48% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2021 stood at $6.4 million (up 250.48% YoY), and the FY2020 full-year result was $4.3 million, up 232.79% from the prior year.
- Capital Leases for Q1 2021 stood at $6.4 million, up from $4.3 million in the prior quarter.
- The five-year high for Capital Leases was $6.4 million in Q1 2021, with the low at $15319.0 in Q1 2017.
- Historically, Capital Leases has averaged $1.8 million across 5 years, with a median of $1.4 million in 2019.
- Annual changes were most pronounced in 2019 — Capital Leases soared 993.69% — and 2020, when it gained 25.33%.
- Adma Biologics' Capital Leases stood at $15319.0 in 2017, then soared by 677.34% to $119080.0 in 2018, then soared by 993.69% to $1.3 million in 2019, then soared by 232.79% to $4.3 million in 2020, then soared by 48.12% to $6.4 million in 2021.
- The last three Capital Leases figures came in at $6.4 million (Q1 2021), $4.3 million (Q4 2020), and $2.9 million (Q3 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 6.42 Mn |
| Dec 31, 2020 | 4.33 Mn |
| Sep 30, 2020 | 2.86 Mn |
| Mar 31, 2020 | 1.83 Mn |
| Dec 31, 2019 | 1.30 Mn |
| Sep 30, 2019 | 1.36 Mn |
| Jun 30, 2019 | 1.41 Mn |
| Mar 31, 2019 | 1.46 Mn |
| Dec 31, 2018 | 119,080.00 |
| Sep 30, 2018 | 126,765.00 |
| Jun 30, 2018 | 134,323.00 |
| Mar 31, 2017 | 15,319.00 |
| Dec 31, 2016 | 19,697.00 |
| Dec 31, 2015 | 36,256.00 |
| Mar 31, 2013 | 74,832.00 |
| Dec 31, 2012 | 77,890.00 |
| Sep 30, 2012 | 81,111.00 |
| Jun 30, 2012 | 83,804.00 |
| Mar 31, 2012 | 86,663.00 |
| Dec 31, 2011 | 88,613.00 |